Advanced search
Publication Cover
Clinical Lipidology Volume 4, 2009 - Issue 5
Submit an article Journal homepage
1,048
Views
4
CrossRef citations to date
0
Altmetric
Reviews

Role of cholesteryl ester hydrolase in atherosclerosis

Shobha GhoshCorrespondence[email protected]
,
Bin Zhao
,
Jinghua Bie
&
Jingmei Song
Pages 573-585 | Published online: 18 Jan 2017

  • Ross R, Agius L: The process of atherogenesis – cellular and molecular interaction: from experimental animal models to humans. Diabetologia 35(Suppl. 2), S34–S40 (1992).
  • Williams KJ, Tabas I: The response-to-retention hypothesis of early atherogenesis. Arterioscler. Thromb. Vasc. Biol. 15(5), 551–561 (1995).
  • Williams KJ, Tabas I: The response-to-retention hypothesis of atherogenesis reinforced. Curr. Opin. Lipidol. 9(5), 471–474 (1998).
  • Kruth HS: Sequestration of aggregated low-density lipoproteins by macrophages. Curr. Opin. Lipidol. 13(5), 483–488 (2002).
  • Kruth HS, Jones NL, Huang W et al.: Macropinocytosis is the endocytic pathway that mediates macrophage foam cell formation with native low density lipoprotein. J. Biol. Chem. 280(3), 2352–2360 (2005).
  • Describe the mechanism of foam cell formation with native rather than modified LDL.
  • Kruth HS, Huang W, Ishii I, Zhang WY: Macrophage foam cell formation with native low density lipoprotein. J. Biol. Chem. 277(37), 34573–34580 (2002).
  • Tabas I: Cholesterol and phospholipid metabolism in macrophages. Biochim. Biophys. Acta 1529, 164–174 (2000).
  • Sliskovic DR, White AD: Therapeutic potential of ACAT inhibitors as lipid lowering and anti-atherosclerotic agents. Trends Pharmacol. Sci. 12, 194–199 (1991).
  • Matsuda K: ACAT inhibitors as antiatherosclerotic agents. Med. Res. Rev. 14, 271–305 (1994).
  • Matsuo M, Ito F, Konto A, Aketa M, Tomoi M, Shimomura K: Effect of FR145237, a novel ACAT inhibitor on atherogenesis in cholesterol fed and WHHl rabbits. Evidence for a direct effect on the arterial wall. Biochem. Biophys. Acta 1259(3), 254–260 (1995).
  • Nicolosi RJ, Wilson TA, Krause BR: The ACAT inhibitor, CI 1011 is effective in the prevention and regression of aortic fatty streak in hamsters. Atherosclerosis 137, 77–85 (1998).
  • Perrey S, Legendre C, Matsuura A et al.: Preferential pharmacological inhibition of macrophage ACAT increases plaque formation in mouse and rabbit models of atherogenesis. Atherosclerosis 155, 359–370 (2001).
  • Accad M, Smith S, Newland D et al.: Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase-1. J. Clin. Invest. 105, 711–719 (2000).
  • Demonstrates the detrimental side effects of acyl-CoA cholesterol acyltransferase (ACAT)-1 inhibition related to accumulation of free cholesterol (FC).
  • Yagu H, Kitamine T, Osuga J et al.: Absence of ACAT-1 attenuates atherosclerosis but causes dry eye and cutaneous xanthomatosis in mice with congenital hyperlipidemia. J. Biol. Chem. 275, 21324–21330 (2000).
  • First to describe that hydrolysis of cholesteryl ester (CE) stored as cytoplasmic lipid droplets is extralysosomal and is catalyzed by a neutral cholesteryl ester hydrolase (CEH).
  • Demonstrates the detrimental side effects of ACAT-1 inhibition related to accumulation of FC.
  • Fazio S, Major AS, Swift LL et al.: Increased atherosclerosis in LDL receptor-null mice lacking ACAT1 in macrophages. J. Clin. Invest. 107, 163–171 (2001).
  • Bocan TM, Krause BR, Rosebury WS et al.: The ACAT inhibitor avasimbe reduces macrophages and matrix metalloproteinase expression in atherosclerotic lesion of hypercholesterolemic rabbits. Arteioscle. Thromb. Vasc. Biol. 20, 70–79 (2000).
  • Glass CK, Witztum JL: Atherosclerosis: the road ahead. Cell 104, 503–516 (2001).
  • Brown MS, Ho YK, Goldstein JL: The cholesteryl ester cycle in macrophage foam cells. Continual hydrolysis and reesterification of cytoplasmic cholesteryl esters. J. Biol. Chem. 255(19), 9344–9452 (1980).
  • Björkhem I, Andersson O, Diczfalusy U et al.: Atherosclerosis and sterol 27-hydroxylase: evidence for a role of this enzyme in elimination of cholesterol from human macrophages. Proc. Natl Acad. Sci. USA 91(18), 8592–8596 (1994).
  • Marcel YL, Ouimet M, Wang MD: Regulation of cholesterol efflux from macrophages. Curr. Opin. Lipidol. 19(5), 455–461 (2008).
  • Comprehensive review of the efflux pathways by which FC is removed from macrophage foam cells.
  • Tall AR, Yvan-Charvet L, Terasaka N, Pagler T, Wang N: HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis. Cell Metab. 7(5), 365–375 (2008).
  • Rothblat GH, de la Llera-Moya M, Favari E, Yancey PG, Kellner-Weibel G: Cellular cholesterol flux studies: methodological considerations. Atherosclerosis 163(1), 1–8 (2002).
  • Excellent review with attention to details needed to perform and interpret FC efflux studies.
  • Ishii I, Oka M, Katto N, Shirai K, Saito Y, Hirose S: b-VLDL-induced cholesterol ester deposition in macrophages may be regulated by neutral cholesterol esterase activity. Arterioscler. Thromb. 12, 1139–1145 (1992).
  • Mathur SN, Field FJ, Megan MB, Armstrong HL: A defect in mobilization of cholesteryl esters in rabbit macrophages. Biochim. Biophys. Acta 834, 48–57 (1985).
  • Yancey PG, St. Clair RW: Mechanism of the defect in cholesteryl ester clearance from macrophages of atherosclerosis-susceptible White Carneau pigeons. J. Lipid Res. 35, 2114–2129 (1994).
  • Goldberg DI, Khoo JC: Stimulation of neutral cholesteryl ester hydrolase by cAMP in P388D1 macrophages. Biochim. Biophys. Acta 1042, 132–137 (1990).
  • Small CA, Goodacre JA, Yeaman SJ: Hormone sensitive lipase is responsible for the neutral cholesteryl ester hydrolase activity in macrophages. FEBS Lett. 247, 205–208 (1989).
  • Khoo JC, Reue K, Steinberg D, Schotz MC: Expression of hormone-sensitive lipase mRNA in macrophages. J. Lipid Res. 34, 1969–1974 (1993).
  • Johnson WJ, Jang SY, Bernard DW: Hormone sensitive lipase mRNA in both monocyte and macrophage forms of the human THP-1 cell line. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 126(4), 543–552 (2000).
  • Reue K, Cohen RD, Schotz MC: Evidence for hormone-sensitive lipase mRNA expression in human monocyte/macrophages. Arterioscler. Thromb. Vasc. Biol. 17(12), 3428–3432 (1997).
  • Li F, Hui DY: Modified low density lipoprotein enhances the secretion of bile salt-stimulated cholesterol esterase by human monocyte-macrophages. Species-specific difference in macrophage cholesteryl ester hydrolase. J. Biol. Chem. 272, 28666–28671 (1997).
  • Harte RA, Hultén LM, Lindmark H et al.:
  • Osuga J, Ishibashi S, Oka T et al.: Targeted disruption of hormone-sensitive lipase results in male sterility and adipocyte hypertrophy, but not in obesity. Proc. Natl Acad. Sci USA 97, 787–792 (2000).
  • Contreras JA: Hormone sensitive lipase is not required for cholesteryl ester hydrolysis in macrophages. Biochem. Biophys. Res. Comm. 292, 900–903 (2002).
  • Escary J, Choy HA, Reue K et al.: Paradoxical effect on atherosclerosis of hormone-sensitive lipase overexpression in macrophages. J. Lipid Res. 40, 397–404 (1999).
  • Gallo LL: Sterol ester hydrolase from rat pancreas. Methods Enzymol. 71(Pt C), 664–674 (1981).
  • Kissel JA, Fontaine RN, Turck CW, Brockman HL, Hui DY: Molecular cloning and expression of cDNA for rat pancreatic cholesterol esterase. Biochim. Biophys. Acta 1006(2), 227–236 (1989).
  • Jacobson PW, Wiesenfeld PW, Gallo LL, Tate RL, Osborne JC Jr: Sodium cholateinduced changes in the conformation and activity of rat pancreatic cholesterol esterase. J. Biol. Chem. 265(1), 515–521 (1990).
  • Hui DY, Kissel JA: Sequence identity between human pancreatic cholesterol esterase and bile salt-stimulated milk lipase. FEBS Lett. 276(1–2), 131–134 (1990).
  • Kodvawala A, Ghering AB, Davidson WS, Hui DY: Carboxyl ester lipase expression in macrophages increases cholesteryl ester accumulation and promotes atherosclerosis. J. Biol. Chem. 280, 38592–38598 (2005).
  • Ghosh S, Grogan WM: Rapid three-step purification of a hepatic neutral cholesteryl ester hydrolase which is not the pancreatic enzyme. Lipids 26(10), 793–798 (1991).
  • Ghosh S, Mallonee DH, Hylemon PB, Grogan WM: Molecular cloning and expression of rat hepatic neutral cholesteryl ester hydrolase. Biochim. Biophys. Acta 1259(3), 305–312 (1995).
  • Ghosh S: Cholesteryl ester hydrolase in human monocyte/macrophage: cloning, sequencing and expression of full-length cDNA. Physiol. Genomics 2, 1–8 (2000).
  • Zhao B, Fisher BJ, St Clair RW, Rudel LL, Shosh S: Redistribution of macrophage cholesteryl ester hydrolase from cytoplasm to lipid droplets upon lipid loading. J. Lipid Res. 46, 2114–2121 (2005).
  • Ghosh S, St Clair RW, Rudel LL: Mobilization of cytoplasmic CE droplets by over-expression of human macrophage cholesteryl ester hydrolase. J. Lipid Res. 44, 1833–1840 (2003).
  • Zhao B, Song J, St Clair RW, Ghosh S: Stable over-expression of human macrophage cholesteryl ester hydrolase (CEH) results in enhanced free cholesterol efflux from human thp1-macrophages. Am. J. Physiol. Cell Physiol. 292(1), C405–C412 (2006).
  • Okazaki H, Igarashi M, Nishi M et al.: Identification of neutral cholesterol ester hydrolase, a key enzyme removing cholesterol from macrophages. J. Biol. Chem. 283(48), 33357–33364 (2008).
  • Escary JL, Choy HA, Reue K, Schotz MC: Hormone-sensitive lipase overexpression increases cholesteryl ester hydrolysis in macrophage foam cells. Arterioscler. Thromb. Vasc. Biol. 18(6), 991–998 (1998).
  • Okazaki H, Osuga J, Tsukamoto K et al.: Elimination of cholesterol ester from macrophage foam cells by adenovirus-mediated gene transfer of hormone-sensitive lipase. J. Biol. Chem. 277(35), 31893–31899 (2002).
  • Adorni MP, Zimetti F, Billheimer JT et al.: The roles of different pathways in the release of cholesterol from macrophages. J. Lipid Res. 48(11), 2453–2462 (2007).
  • Crow JA, Middleton BL, Borazjani A, Hatfield MJ, Potter PM, Ross MK: Inhibition of carboxylesterase 1 is associated with cholesteryl ester retention in human THP-1 monocyte/macrophages. Biochim. Biophys. Acta 1781(10), 643–654 (2008).
  • First study to describe the presence of SR-BII and its role in delivery of HDL–CE.
  • First report describing removal of cholesterol from macrophages following conversion to 27-hydoxycholesterol, establishing a novel mechanism for FC removal from macrophage foam cells.
  • Wang N, Lan D, Chen W, Matsuura F, Tall AR: ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc. Natl Acad. Sci. USA 101(26), 9774–9779 (2004).
  • Provides the possible mechanism for the sequential lipidation of ApoA-I during the process of FC efflux from macrophages.
  • Connelly MA, Williams DL: Scavenger receptor BI: a scavenger receptor with a mission to transport high density lipoprotein lipids. Curr. Opin. Lipidol. 15, 287–295 (2004).
  • Excellent review summarizing the role of scavenger receptor class B, Type I (SR-BI) in delivery of HDL–CE.
  • Webb NR, Connell PM, Graf GA et al.: SR-BII, an isoform of the scavenger receptor BI containing an alternate cytoplasmic tail, mediates lipid transfer between high density lipoprotein and cells. J. Biol. Chem. 273, 15241–15248 (1998).
  • Escary JL, Choy HA, Reue K et al.: Paradoxical effect on atherosclerosis of hormone-sensitive lipase overexpression in macrophages. J. Lipid Res. 40(3), 397–404 (1999).
  • Choy HA, Wang XP, Schotz MC: Reduced atherosclerosis in hormone-sensitive lipase transgenic mice overexpressing cholesterol acceptors. Biochim. Biophys. Acta 1634(3), 76–85 (2003).
  • Zhao B, Song J, Chow WN et al.: Macrophage-specific transgenic expression of cholesteryl ester hydrolase significantly reduces atherosclerosis and lesion necrosis in Ldlr mice. J. Clin. Invest. 117(10), 2983–2992 (2007).
  • Sparrow CP, Pittman RC: Cholesterol esters selectively taken up from high density lipoproteins are hydrolyzed extralysosomally. Biochim. Biophys. Acta 1043, 203–210 (1990).
  • Summarizes the various aspects of regulation of catalysis by lipases at water–lipid interfaces.
  • DeLamatre JG, Carter RM, Hornick CA: Evidence that a neutral cholesteryl ester hydrolase is responsible for the extralysosomal hydrolysis of high-density lipoprotein cholesteryl ester in rat hepatoma cells (Fu5AH). J. Cell Physiol. 157, 164–168 (1993).
  • Connelly MA, Kellner-Weiber G, Rothblat GH et al.: Scavenger receptor, class B, type I (SR-BI)-directed HDLcholesteryl ester hydrolysis. J. Lipid Res. 44, 331–341 (2003).
  • First study demonstrating increased CE accumulation by pharmacological inhibition of CEH/Ces1.
  • Describes the role of hormone-sensitive lipase (HSL) in the hydrolysis of SR-BI delivered CE in adrenal glands and emphasizes that the enzyme responsible for similar hydrolysis in liver and other tissues is not characterized.
  • Kraemer FB, Shen W-J, Harada K et al.: Hormone-sensitive lipase is required for HDL cholesteryl ester-supported adrenal steroidogenesis. Mol. Endocrinol. 18, 549–557 (2004).
  • Harrison EH: Bile salt-dependent, neutral cholesteryl ester hydrolase of rat liver: possible relationship with pancreatic cholesteryl ester hydrolase. Biochim. Biophys. Acta 963(1), 28–34 (1988).
  • Camulli ED, Linke MJ, Brockman HL, Hui DY: Identity of a cytosolic neutral cholesterol esterase in rat liver with the bile salt stimulated cholesterol esterase in pancreas. Biochim. Biophys. Acta 1005(2), 177–182 (1989).
  • Chen X, Harrison EH, Fisher EA: Molecular cloning of the cDNA for rat hepatic, bile salt-dependent cholesteryl ester/retinyl ester hydrolase demonstrates identity with pancreatic carboxylester lipase. Proc. Soc. Exp. Biol. Med. 215(2), 186–191 (1997).
  • Natarajan R, Ghosh S, Grogan W: Catalytic properties of the purified rat hepatic cytosolic cholesteryl ester hydrolase. Biochem. Biophys. Res. Commun. 225, 413–419 (1996).
  • Reis P, Holmberg K, Watzke H et al.: Lipases at interfaces: a review. Adv. Colloid. Interface Sci. 147–148, 237–250 (2009).
  • Carefully examines the effects of substrate presentation on the activity of CEHs.
  • Deykin D, Goodman DS: The hydrolysis of long-chain fatty acid esters of cholesterol with rat liver enzymes. J. Biol. Chem. 237, 3649–3656 (1962).
  • Quantifies, for the first time, the contribution of various FC efflux pathways to total efflux from macrophage foam cells.
  • Natarajan R, Ghosh S, Grogan WM: Age-related changes in mRNA, protein and catalytic activity of hepatic neutral cholesterol ester hydrolase in male rats: evidence for transcriptional regulation. Biochim. Biophys. Acta 1302(2), 153–158 (1996).
  • Natarajan R, Ghosh S, Grogan WM: Molecular cloning of the promoter for rat hepatic neutral cholesterol ester hydrolase: evidence for transcriptional regulation by sterols. Biochem. Biophys. Res. Commun. 243(2), 349–355 (1998).
  • Ghosh S, Natarajan R, Pandak WM, Hylemon PB, Grogan WM: Regulation of hepatic neutral cholesteryl ester hydrolase by hormones and changes in cholesterol flux. Am. J. Physiol. 274(4 Pt 1), G662–G668 (1998).
  • Zhao B, Natarajan R, Ghosh S: Human liver cholesteryl ester hydrolase: cloning, molecular characterization, and role in cellular cholesterol homeostasis. Physiol. Genomics 23(3), 304–310 (2005).
  • Lehner R, Vance DE: Cloning and expression of a cDNA encoding a hepatic microsomal lipase that mobilizes stored triacylglycerol. Biochem J. 343, 1–10 (1999).
  • Provides the first in vivo proof-of-concept that enhancing macrophage CE hydrolysis is indeed anti-atherosclerotic and identifies CEH as a potential therapeutic target to attenuate coronary artery disease.
  • Zhao B, Song J, Ghosh S: Hepatic overexpression of cholesteryl ester hydrolase enhances cholesterol elimination and in vivo reverse cholesterol transport. J. Lipid Res. 49(10), 2212–2217 (2008).
  • Zhang Y, Zanotti I, Reilly MP, Glick JM, Rothblat GH, Rader DJ: Overexpression of apolipoprotein A-I promotes reverse transport of cholesterol from macrophages to feces in vivo. Circulation 108, 661–663 (2003).
  • Describe the first method to quantify in vivo reverse cholesterol transport and measure the cholesterol elimination in feces.
  • Holm C, Belfrage P, Fredrikson G: Immunological evidence for the presence of hormone-sensitive lipase in rat tissues other than adipose tissue. Biochem. Biophys. Res. Commun. 148(1), 99–105 (1987).
  • Sekiya M, Osuga J, Yahagi N et al.: Hormone-sensitive lipase is involved in hepatic cholesteryl ester hydrolysis. J. Lipid Res. 49(8), 1829–3188 (2008).
  • Fernandez C, Lindholm M, Krogh M et al.: Disturbed cholesterol homeostasis in hormone-sensitive lipase-null mice. Am. J. Physiol. Endocrinol. Metab. 295 (4), E820–E831 (2008).
  • Camarota LM, Chapman JM, Hui DY et al.: Carboxyl ester lipase cofractionates with scavenger receptor BI in hepatocyte lipid rafts and enhances selective uptake and hydrolysis of cholesteryl esters from HDL3. J. Biol. Chem. 279, 27599–27606 (2004).
  • Nomura DK, Durkin KA, Chiang KP et al.: Serine hydrolase KIAA1363: toxicological and structural features with emphasis on organophosphate interactions. Chem. Res. Toxicol. 19, 1142–1150 (2006).
  • Wei E, Alam M, Sun F et al.: Apolipoprotein B and triacylglycerol secretion in human triacylglycerol hydrolase transgenic mice. J. Lipid Res. 48, 2597–2606 (2007).
  • Ghosh S, Natarajan R: Cloning of the human cholesteryl ester hydrolase promoter: identification of functional peroxisomal proliferator-activated receptor responsive elements. Biochem. Biophys. Res. Commun. 284(4), 1065–1070 (2001).
  • Zhao B, Song J, Arrowood J, Ghosh S: Variations in the expression of cholesteryl ester hydrolase in macrophages from human subjects and its relationship to coronary artery disease (CAD): a pilot study. Circulation Suppl II. 114 (18), 679 (2006).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.